Chanwuyi Lifestyle Medicine Program Alleviates Immunological Deviation and Improves Behaviors in Autism

Prof. Agnes S. CHAN (Corresponding Author), Yvonne Ming Yee Han, Sophia L. Sze, Prof. Wong Chun-kwok, Ida M.T. Chu, Cheung Mei-chung

Research output: Journal article publicationJournal articleAcademic researchpeer-review


Given the association between deviated inflammatory chemokines, the pathogenesis of autism spectrum disorders (ASD), and our previous findings of the Chanwuyi Lifestyle Medicine Program regarding improved cognitive and behavioral problems in ASD, the present study aims to explore if this intervention can alter pro-inflammatory chemokines concentration. Thirty-two boys with ASD were assigned to the experimental group receiving the Chanwuyi Lifestyle Medicine Program for 7 months or the control group without a change in their lifestyle. The experimental group, but not the control group, demonstrated significantly reduced CCL2 and CXCL8, a trend of reduction in CCL5, and elevation of CXCL9. The experimental group also demonstrated significantly reduced social communication problems, repetitive/stereotypic behaviors, and hyperactive behaviors. The present findings support the potential efficacy and applicability of the Chanwuyi Lifestyle Medicine Program for reducing both behavioral problems and immunological dysfunction in ASD. Further studies are warranted to verify its treatment effect and its association with brain functions.
Original languageEnglish
Article numberneurosci2020015
Pages (from-to)207-223
Number of pages17
Issue number2
Publication statusPublished - 7 Jun 2021


  • autism spectrum disorders
  • intervention
  • chemokines
  • pro-inflammatory
  • behavioral problems

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this